South Africa

Resilience System

Main menu


FDA approves Pfizer vaccines for younger teens, 12-15

Indian government concerned about "black fungus" in COVID-19 patients

'Black Fungus' Complication Adds to India's COVID Woes

BENGALURU (Reuters) - The Indian government has told doctors to look out for signs of mucormycosis or "black fungus" in COVID-19 patients as hospitals report a rise in cases of the rare but potentially fatal infection.

The state-run Indian Council of Medical Research (ICMR) said at the weekend that doctors treating COVID-19 patients, diabetics and those with compromised immune systems should watch for early symptoms including sinus pain or nasal blockage on one side of the face, one-sided headache, swelling or numbness, toothache and loosening of teeth.

The disease, which can lead to blackening or discolouration over the nose, blurred or double vision, chest pain, breathing difficulties and coughing blood, is strongly linked to diabetes. And diabetes can in turn be exacerbated by steroids such as dexamethasone, used to treat severe COVID-19.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Herd immunity unlikely: The world may need to live with the virus

The world may need to learn to live with the virus.

Early in the pandemic, there was hope that the world would one day achieve herd immunity, the point when the coronavirus lacks enough hosts to spread easily. But over a year later, the virus is crushing India with a fearsome second wave and surging in countries from Asia to Latin America.

Experts now say it is changing too quickly, new more contagious variants are spreading too easily and vaccinations are happening too slowly for herd immunity to be within reach anytime soon.

That means if the virus continues to run rampant through much of the world, it is well on its way to becoming endemic, an ever-present threat.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Considerations in flying safely a year into the pandemic

India's vaccination campaign falters amid growing number of coronavirus cases.

Some countries, especially in Africa, still have no COVID-19 vaccines

EU to buy more Pfizer-BioNTech but not AstraZenca vaccines

'No doubt' US has undercounted COVID-19 deaths--Dr. Fauci

U.S. turning corner on pandemic, says White House COVID coordinator

EU steps up criticism of US willingness to waive patents on coronavius vaccines

Overview of what's known about the coronavirus variants

Preparations are underway for potential Covid-19 vaccine boosters, CDC director says

India's coronavirus surge deepens, prompting more lockdown efforts

Description of how India's major vaccine producer fell short of promises to inoculate the world's poor

 

NEW DELHI — Adar Poonawalla made big promises. The 40-year-old chief of the world’s largest vaccine maker pledged to take a leading role in the global effort to inoculate the poor against Covid-19. His India-based empire signed deals worth hundreds of millions of dollars to make and export doses to suffering countries.

Those promises have fallen apart. India, engulfed in a coronavirus second wave, is laying claim to his vaccines. Other countries and aid groups are now racing to find scarce doses elsewhere.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Efforts to vaccinate the world lagging despite steps to provide more doses

Even with more vaccines on the horizon, much of the world will most likely keep waiting for doses

The World Health Organization approved one Chinese-made Covid-19 vaccine and could soon approve another. The Biden administration has backed waiving intellectual property protections for vaccines, which could make it easier for more countries to make them.

But the campaign to vaccinate the world is floundering, and experts warn it will take more to reverse the trend.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to South Africa RSS
howdy folks
Page loaded in 1.443 seconds.